Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1236-1243

  Pise Masison, Cynthia A ^a   Dittmer, Jürgen ^a,c   Clemens, Karen E ^a,d   Brady, John N ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL INTERACTION; CELL TRANSFORMATION; DNA BINDING; DNA LIBRARY; ENZYME ASSAY; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0031017531     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1236     Document Type: Article

References (93)

1. Adya, N., L.-J. Zhao, W. Huang, I. Boros, and C.-Z. Giam. 1994. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc. Natl. Acad. Sci. USA 91:5642-5646.
2. Agoff, S. N., J. Hou, D. I. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
3. Akari, H., Y. Goto, and T. Shinjo. 1995. Detection of the cellular membrane proteins on human T cell leukemia virus type I. Arch. Virol. 140:375-382.
4. Anderson, M. G., and W. S. Dynan. 1994. Quantitative studies of the effect of HTLV-I Tax protein on CREB protein-DNA binding. Nucleic Acids Res. 22:3194-3201.
5. Armstrong, A. P., A. A. Franklin, M. N. Uittenbogaard, H. A. Geibler, and J. K. Nyborg. 1993. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc. Natl. Acad. Sci. USA 90:7303-7307.
6. Ausubel, F. M., R. Brent, R. Kingston, D. Moore, J. J. Seidman, J. Smith, and K. Struhl. 1994. Current protocols in molecular biology. John Wiley and Sons, New York, N.Y.
7. Baranger, A. M., C. R. Palmer, M. K. Hamm, H. A. Giebler, A. Brauweller, J. K. Nyborg, and A. Schepartz. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature (London) 376:606-608.
8. Baxevanis, A. D., G. Arents, E. N. Moudrianakis, and D. Landsman. 1995 A variety of DNA-binding and multimeric proteins contain the histone fold motif. Nucleic Acids Res. 23:2685-2691.
9. Boulikas, T. 1993. Nuclear localization (NSL). Crit. Rev. Eukaryotic Gene Expression 3:193-227.
10. Brauweiler, A., P. Garl, A. A. Franklin, H. A. Giebler, and J. K. Nyborg. 1995. A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation. J. Biol. Chem. 270:12814-12822.
11. Brodsky, F. M., and L. E. Guagliardi. 1991. The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 9:707-744.
12. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA 90:2532-2536.
13. Bryans, M., L. M. Lucas, T. J. Knoboch, N. M. Wilkie, and J. C. Lang. 1995. Regulation of FGF-4 enhancer activity by transcription factor NF-Y. Biochem. Biophys. Res. Commun. 211:519-527.
14. Chang, Z.-F., and C.-J. Liu. 1994. Human thymidine kinase CCAAT-binding protein NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblast. J. Biol. Chem. 269:17893-17898.
15. Chen, H., J. Campisi, and R. Padmanabhan. 1996. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J. Biol. Chem. 27:13959-13967.
16. Clemens, K. E., G. Piras, M. F. Radonovich, K.-S. Choi, J. F. Duvall, J. DeJong, R. Roeder, and J. N. Brady. 1996. Interaction of the human T-cell lymphotropic virus type 1 Tax transactivation with transcription factor IIA. Mol. Cell. Biol. 16:4656-4664.
17. Cogswell, J. P., N. Zeleznik-Le, and J. P.-Y. Ting. 1991. Transcriptional regulation of the HLA-DRA gene. Crit. Rev. Immunol. 11:87-112.
18. Daenke, S., S. Nightingale, J. K. Cruickshank, and C. R. M. Bangham. 1990. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J. Virol. 64:1278-1282.
19. Dittmer, J., S. D. Gitlin, R. L. Reid, and J. N. Brady. 1993. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1. J. Virol. 67:6087-6095.
20. Dorn, A., J. Bollekens, A. Straub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT box-binding proteins. Cell 50:863-872.
21. Filatov, D., and L. Thelander. 1995. Role of a proximal NF-Y binding promoter element in S phase-specific expression of mouse ribonucleotide reductase R2 gene. J. Biol. Chem. 270:25239-25243.
22. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
23. Franklin, A. A., and J. K. Nyborg. 1995. Mechanism of Tax regulation of human T cell leukemia virus type I gene expression. J. Biomed. Sci. 2:17-29.
24. Franklin, A. A., M. F. Kubik, M. N. Uittenbogaard, A. Brauweiler, P. Utaisincharoen, M.-A. H. Matthews, W. S. Dynan, J. P. Hoeffler, and J. K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J. Biol. Chem. 268:21225-21231.
25. Fukushima, A., and H. Ueno. 1995. The relationship between HTLV-1-infected cell lines and uveitis. Graefes. Arch. Clin. Exp. Ophthalmol. 233: 231-235.
26. Gazzolo, L., and M. Duc Dodon. 1987. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature (London) 326:714-717.
27. Gessain, A., F. Saal, O. Gout, M. T. Daniel, G. Flandrin, G. de The, J. Peries, and F. Sigaux. 1990. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 75: 428-433.
28. Grassman, R., S. Berchtold, I. Radant, M. Alt, B. Fleckenstein, J. G. Sodroski, W. A. Haseltine, and U. Ramstedt. 1992. Role of human T-cell leukemia virus type I X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:4570-4575.
29. Grassman, R., C. Dengler, I. Muller-Fleckenstein, K. McGuire, M. C. Dokhler, J. G. Sodroski, and W. A. Haseltine. 1989. Transformation to continuos growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 86:3351-3355.
30. Gregersen, P. K. 1989. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab. Invest. 61:5-19.
31. Hall, W., C. R. Liu, O. Schneewind, H. Takahashi, M. H. Kaplan, G. Roupe, and A. Vahlne. 1991. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253:317-320.
32. Hasan, S., T. Koda, and M. Kakinuma. 1994. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cell. J. Biol. Chem. 269:25042-25048.
33. Hasunuma, T., T. Nakajima, H. Ano, et al. 1994. Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-I. Clin. Immunol. Immunopathol. 72:90-97.
34. Hinrichs, S. H., M. Nerenberg, R. K. Reynolds, G. Khoury, and G. A. Jay. 1987. A transgenic mouse model for human neurofibromatosis. Science 237:1340-1343.
35. Hirai, H., T. Suzuki, J. Fujisawa, J. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584-3588.
36. Hiscott, J., L. Petropoulos, and J. Lacoste. 1995. Molecular interactions between HTLV-I Tax protein and the NF-kappa B transcription complex. Virology 214:3-11.
37. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
38. Iwakura, Y., S. Saijo, Y. Kioka, J. Nakayama-Yamada, K. Itagaki, M. Tosu, M. Asano, Y. Kanai, and K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588-1598.
39. Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I in patients with HTLV-I-associated neurological disease. Nature (London) 348:245-248.
40. Jacobson, S., J. S. Reuben, R. D. Streilein, and T. J. Palker. 1991. Induction of CD4+, human T lymphotropic type-I-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-I. J. Immunol. 146:1155-1162.
41. Kannagi, M., S. Matsushita, H. Shida, and S. Harada. 1994. Cytotoxic T cell response and expression of the target antigen in HTLV-infection. Leukemia 8(Suppl. 1):S54-S59.
42. Kanno, T., K. Brown, G. Franzoso, and U. Siebenlist. 1994. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-kappa B via stimulation of signaling pathways. Mol. Cell. Biol. 14:6443-6451.
43. Kimata, J. T., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:4398-4407.
44. Kinoshita, T., A. Tsujimoto, K. Shimotohno, and T. Sugimura. 1991. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int. J. Cancer 47:491-495.
45. Kira, J., Y. Itoyama, Y. Koyanagi, J. Tateishi, M. Kishikawa, S. Akizuki, I. Kobayashi, N. Toki, K. Sueishi, H. Sao, et al. 1992. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann. Neurol. 31:39-45.
46. LaGrenada, L., B. Hanchard, V. Fletcher, B. Cranston, and W. Blattner. 1990. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336:1345-1347.
47. Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol. 68:1854-1863.
48. Lindholm, P. F., F. Kashanchi, and J. N. Brady. 1993. Transcriptional regulation in the human retrovirus HTLV-I. Semin. Virol. 4:53-60.
49. Li-Weber, M., I. V. Davydov, H. Krafft, and P. H. Krammer. 1994. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153:4122-4133.
50. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
51. Mach, B. 1995. MHC class II regulation-lessons from a disease. N. Engl. J. Med. 332:120-122.
52. Maity, S. N., S. Sinha, E. C. Ruteshousher, and B. de Crombrugghe. 1992. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J. Biol. Chem. 267:16574-16580.
53. Mann, D. L., P. DeSantis, G. Mark, A. Pfeifer, M. Newman, N. Gibbs M. Popovic, M. G. Sarngadharan, R. C. Gallo, J. Clark, and W. Blattner. 1987. HTLV-I associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science 236:1103-1106.
54. Marcil, R., and D. R. Higgins. 1992. Direct transfer of plasmid DNA from yeast to E. coli by electroporation. Nucleic Acids Res. 20:917.
55. Matsuzaki, Y., J.-I. Fujisawa, and M. Yoshida. 1995. Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-I enhancer. J. Biochem. 117:303-308.
56. Matthews, M.-A. H., R.-B. Markowitz, and W. S. Dynan. 1992. In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein. Mol. Cell. Biol. 12:1986-1996.
57. McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard. 1996. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type I: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 16:2083-2090.
58. Monaco, J. J. 1993. Structure and function of genes in the MHC class II region. Curr. Opin. Immunol. 5:17-20.
59. Mori, M., B. Nobutaro, and K. Kinoshita. 1988. Familial occurrence of HTLV-associated myelopathy. Ann. Neurol. 23:100.
60. Mukhopadhyaya, R., and M. R. Sadaie. 1993. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM. Comparison to other HTLV-I isolates. AIDS Res. Hum. Retroviruses 9:109-114.
61. Munoz, E., and A. Israel. 1995. Activation of NF-kappa B by the Tax protein of HTLV-I. Immunobiol. 193:128-136.
62. Nerenberg, M., S. Hinrichs, R. Reynolds, G. Khoury, and G. A. Jay. 1987. The tat gene of human T-lymphotropic virus type I induces mesenchymal tumors in transgenic mice. Science 237:1324-1329.
63. Nishioka, K., I. Maruyama, K. Sato, I. Kitajima, Y. Nakajima, and M. Osame. 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet i:441.
64. Noraz, N., B. Verrier, C. Fraisier, and C. Desgranges. 1995. Cell surface phenotype changes induced in H9 T cells chronically infected with HTLV type I or HIV tvpe I or coinfected with the two viruses. AIDS Res. Hum. Retroviruses 11:145-154.
65. Ohshima, K., M. Kikuchi, Y. Masuda, Y. Sumiyoshi, F. Eguchi, H. Montai, M. Takeshita, and N. Kimura. 1992. Human T-cell leukemia virus type I associated lymphadenitis. Cancer 69:239-248.
66. Paca-Uccaralertkun, S., L.-J. Zhao, N. Adya, J. V. Cross, B. R. Cullen, I. Boros, and C.-Z. Giani. 1994. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator. Tax. Mol. Cell. Biol. 14:456-462.
67. Pozzatti, R., J. Vogel, and G. A. Jay. 1990. The human T lymphotropic virus type I tax gene can cooperate with ras oncogene to induce neoplastic transformation in cells. Mol. Cell. Biol. 10:413-417.
68. Reith, W., V. Steimle, B. Durand, M. Kobr, and B. Mach. 1995. Regulation of MHC class II gene expression. Immunobiology 193:248-253.
69. Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91: 554-558.
70. Sartoris, S., and R. S. Accolla. 1995. Transcriptional regulation of MHC class II genes. Int. J. Clin. Lab. Res. 25:71-78.
71. Schmidt, E. E., and U. Schibler. 1995. Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. J. Cell Biol. 128:467-483.
72. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
73. Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7:1266-1276.
74. Shirabe, S., T. Nakamura, M. Tsujihata, S. Nagataki, M. Seiki, and M. Yoshida. 1990. Retrovirus from human T-cell leukemia virus type I associated myelopathy is the same strain as a prototype human T-cell leukemia virus type I. Arch. Neurol. 47:1258-1260.
75. Sinha, S., I.-S. Kim, K.-Y. Sohn, B. de Crombrugghe, and S. N. Maity. 1996. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol. Cell. Biol. 16:328-337.
76. Sinha, S., S. N. Maity, J. Lu, and B. de Crombrugghe. 1995. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. USA 92:1624-1628.
77. Smith, M. R., and W. C. Greene. 1991. Type I human T-cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J. Clin. Invest. 88:1038-1042.
78. Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
79. Stone, D. M., A. J. Hof, and W. C. Davis. 1995. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet. Immunol. Immunopathol. 48:65-76.
80. Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
81. Suzuki, T., J.-I. Fujisawa, M. Toita, and M. Yoshida. 1993. The transactivator tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I. Proc. Natl. Acad. Sci. USA 90:610-614.
82. Tanka, A., C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, and M. Hatanaka. 1990. Oncogenic transformation by the Tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA 87:1071-1075.
83. Wagner, S., and M. R. Green. 1993. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395-399.
84. Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. Badley Clarke, and J. P.-Y. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042-4053.
85. Yamaoka, S., H. Inoue, M. Sakurai, T. Sugiyama, M. Hazama, T. Yamada, and M. Hatanaka. 1996. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 15:873-887.
86. Yoshida, M. 1993. HTLV-I Tax: regulation of gene expression and disease. Trends Microbiol. 1:131-135.
87. Yoshida, M., M. Osame, K. Usuki, M. Matsumoto, and A. Igata. 1987. Virus detected in HTLV-I-associated myelopathy and adult T-cell leukemia are identical on DNA blotting. Lancet i:1085-1086.
88. Yoshida, M., M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda, et al. 1989. Increased replication of HTLV-I in HTLV-associated myelopathy. Ann. Neurol. 26:331-335.
89. Zeleznik-Le, N. J., J. C. Azizkhan, and J. P.-Y. Ting. 1991. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873-1837.
90. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mix1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.
91. Zhao, L.-J., and C.-Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 89:7070-7074.
92. Zhao, T. M., M. A. Robinson, F. S. Bowers, and T. J. Kindt. 1995. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol. 69:2024-2030.
93. Zwicker, J., C. Gross, F. C. Lucibello, M. Truss, F. Ehlert, K. Engeland, and R. Muller. 1995. Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 23:3822-3830.